Abstract:Roux-en-Y gastric bypass (RYGB) is the gold standard bariatric surgical intervention in obese patients with pre-operative gastroesophageal reflux disease (GERD) [1]. Several hypotheses have been proposed to explain GERD recurrence postoperatively, including retained acid-secreting parietal cells in the pouch [2], dysmotility of the Roux limb, and herniation of the gastric pouch through the hiatus. We report the successful treatment of refractory GERD following RYGB using anti-reflux mucosal ablation (ARMA) ([Fig. 1]). A 54-year-old woman with a history of RYGB presented with symptoms of GERD, including significant regurgitation and a sour taste in her mouth, which affected her quality of life (GERD-Q score 15). Esophagogastroduodenoscopy revealed a 3-cm hiatal hernia with an American Foregut Society (AFS) hiatus classification of 4 [3], a medium-sized pouch, and a patent gastrojejunostomy. Examination of the gastroesophageal junction revealed loss of an effective flap valve. Wireless capsule pH monitoring revealed a total of 0% acid exposure time, as expected following RYGB. A barium esophagram confirmed a small sliding hiatal hernia with regurgitation. She declined surgical hiatal hernia repair for fear of adverse events. She was offered ARMA for symptom control, to which she agreed ([Video 1]). Follow-up endoscopy 4 weeks after ARMA showed significant improvement in the hiatal defect, with an improvement in AFS classification to hiatus grade 1. At 6 months post-ARMA, she reported significant improvement in quality of life (GERD-Q score of 6), with resolution of regurgitation and no dysphagia. Given the altered anatomy after RYGB, management of refractory GERD can be challenging. Laparoscopic hiatal hernia repair and radiofrequency ablation of the gastroesophageal junction (Stretta procedure) have been reported [4]. Our case demonstrates that ARMA may be an additional therapeutic option. First described by Hernández Mondragón et al. [5] in 2020, ARMA likely exhibits its beneficial effects by remodeling the gastroesophageal junction, leading to decreased proximal gastric distensibility. Endoscopy_UCTN_Code_TTT_1AO_2AJ E-Videos is an open access online section of the journal Endoscopy , reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/). This section has its own submission website athttps://mc.manuscriptcentral.com/e-videos. Article published online: 09 January 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Effect of anti-reflux suture on gastroesophageal reflux symptoms after one anastomosis gastric bypass: a randomized controlled trial

The Effect of Revisional One Anastomosis Gastric Bypass After Sleeve Gastrectomy on Gastroesophageal Reflux Disease, Compared with Revisional Roux-en-Y Gastric Bypass: Symptoms and Quality of Life Outcomes

Esophageal function and non-acid reflux evaluated by impedance-24 h-pH-metry, high-resolution manometry, and gastroscopy after one-anastomosis gastric bypass—outcomes of a prospective mid-term study

The Impact of Cholecystectomy on Bile Reflux After One Anastomosis Gastric Bypass

Efficacy of One-Anastomosis Gastric Bypass Versus Roux‐en‐Y Gastric Bypass for Gastroesophageal Reflux Disease: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

The effect of laparoscopic vertical sleeve gastrectomy and laparoscopic roux-en-Y gastric bypass on gastroesophageal reflux disease: An updated meta-analysis and systematic review of 5-year post-operative data from randomized controlled trials

Clinical influence of conversion of laparoscopic sleeve gastrectomy to one anastomosis gastric bypass on gastroesophageal reflux disease

Long-Term Evaluation of Biliary Reflux After Experimental One-Anastomosis Gastric Bypass in Rats

Short-term gut microbiota's shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial

Analysis of Factors Related to Gastroesophageal Reflux After Gastric Bypass at 10-Year Follow-up: A Retrospective Single-institutional Study

Laparoscopic Roux-Y-gastric bypass versus laparoscopic one-anastomosis gastric bypass for obesity: clinical & metabolic results of a prospective randomized controlled trial

One Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass: A Randomized Prospective Trial

Evolution of gastroesophageal reflux disease symptoms after bariatric surgery: A dose-response meta-analysis

A 3-Arm case-matched analysis of anti-reflux reconstruction methods after laparoscopic proximal gastrectomy - Single tract jejunal interposition vs double tract reconstruction vs tube-like stomach reconstruction

Comparison of three different anastomotic methods of sleeve gastrectomy with transit bipartition using an obese rodent model

Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts' Modified Delphi Consensus

Effect of Esophagus-Remnant Stomach Anterior Wall Anastomosis on Postoperative Reflux and Nutritional Status in Patients with Early- and Intermediate-Stage Proximal Gastric Cancer

The effect of bariatric surgery type on cardiac reverse remodelling

One Anastomosis Gastric Bypass as Revisional Surgery Following Sleeve Gastrectomy: A Systematic Review and Meta-Analysis

Laparoscopic sleeve gastrectomy vs one-anastomosis gastric bypass 5-year follow-up: a single-blinded randomized controlled trial

Anti-reflux mucosal ablation for refractory gastroesophageal reflux disease after Roux-en-Y gastric bypass